Aquacel surgical dressing reduces the rate of acute PJI following total joint arthroplasty: A case-control study

Journal of Arthroplasty

Volumn 29, Issue 6, 2014, Pages 1098-1100

  Cai, Jenny ^a   Karam, Joseph A ^a   Parvizi, Javad ^a   Smith, Eric B ^a   Sharkey, Peter F ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Hip arthroplasty; Knee arthroplasty; Periprosthetic joint infection; Wound dressing

Indexed keywords

CEFAZOLIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL PRACTICE; HEALTH CARE COST; HUMAN; KNEE PROSTHESIS; MAJOR CLINICAL STUDY; MONOTHERAPY; PERIPROSTHETIC JOINT INFECTION; RISK FACTOR; RISK REDUCTION; SURGICAL PATIENT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND DRESSING;

HIP ARTHROPLASTY; KNEE ARTHROPLASTY; PERIPROSTHETIC JOINT INFECTION; WOUND DRESSING;

ANTI-INFECTIVE AGENTS; ARTHROPLASTY, REPLACEMENT; BANDAGES; CARBOXYMETHYLCELLULOSE SODIUM; CASE-CONTROL STUDIES; HUMANS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; WOUND HEALING;

EID: 84901007340     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.11.012     Document Type: Article

References (22)

1. Adeli B., Parvizi J. Strategies for the prevention of periprosthetic joint infection. J Bone Joint Surg 2012, 94(11 Suppl A):42.
2. Bozic K.J., Ong K., Lau E., et al. Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res 2013, 471(2):574.
3. Berbari E.F., Hanssen A.D., Duffy M.C., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998, 27:1247.
4. Parvizi J., Pawasarat I.M., Azzam K.A., et al. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. JOA 2010, 25(6 Sup):103.
5. Cataldo M.A., Petrosillo N., Cipriani M., et al. Prosthetic joint infection: recent developments in diagnosis and management. J Infect 2010, 61(6):443.
6. Fisman D.N., Reilly D.T., Karchmer A.W., et al. Clinical effectiveness and cost effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001, 32(3):419.
7. Pulido L., Ghanem E., Joshi A., et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008, 466(7):1710.
8. Berg A., Fleischer S., Kuss O., et al. Timing of dress removal in the healing of surgical wounds by primary intention: quantitative systematic review protocol. J Adv Nurs 2011, 68(2):264.
9. Vasconcelos A., Cavaco-Paulo Artur Wound dressings for a proteolytic-rich environment. Appl Microbiol Biotechnol 2011, 90(2):445.
10. Hutchinson J.J., McGuckin M. Occlusive dressings: a microbiologic and clinical review. Am J Infect Control 1990, 18(4):257.
11. Hopper G.P., Deakin A.H., Crane E.O., et al. Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit. J Wound Care 2012, 21(4):200.
12. Parvizi J., Zmistowski B., Berbari E.F., et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011, 469(11):2992.
13. Kurtz S.M., Lau E., Watson H., et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012, 27(8, Supplement):61.
14. Pulido L., Ghanem E., Joshi A., et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008, 466(7):1710.
15. Berbari E.F., Osmon D.R., Lahr B., et al. The Mayo Joint Infection Risk Score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 2012, 33(8):774.
16. Okumura C.Y.M., Hollands A., Tran D.N., et al. A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J Mol Med 2012, 90(9):1079.
17. Jones S.A., Bowler P.G., Walker M., et al. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen 2004, 12(3):288.
18. Hopper G.P., Deakin A.H., Crane E.O., et al. Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit. J Wound Care 2012 Apr, 21(4):200.
19. Kurtz S.M., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007, 89:780.
20. Brown N.M., Cipriano C.A., Moric M., et al. Dilute betadine lavage before closure for the prevention of acute postoperative deep periprosthetic joint infection. J Arthroplasty 2012, 27(1):27.
21. Smith E.B., Wynne R., Joshi A., et al. Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients?. J Arthroplasty 2012, 27(8 Suppl):55. [Epub 2012 May 17]. 10.1016/j.arth.2012.03.040.
22. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999, 27(2):97.